The hope is that activating sirtuins in people would, like a calorically restricted diet in mice, avert degenerative diseases of aging like diabetes, heart disease, cancer and Alzheimer’s. There is no Food and Drug Administration category for longevity drugs, so if the company is to submit a drug for approval, it needs to be for a specific disease.
Tuesday, July 22, 2008
Hoping Two Drugs Carry a Side Effect: Longer Life
By NICHOLAS WADE
Published: July 22, 2008, New York Times
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment